echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > JACC: Considering both systolic and diastolic blood pressure, how should the control target be set?

    JACC: Considering both systolic and diastolic blood pressure, how should the control target be set?

    • Last Update: 2021-11-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Systolic and diastolic blood pressure and heart vascular events have important implications, but rarely consider at the same time
    .
    The current guidelines set the goal of hypertension treatment below 140/90 (or 130/80) mmHg, and the goal of systolic blood pressure control for stroke prevention is lower.


    At the same time, for patients with coronary heart disease, diastolic blood pressure cannot be lowered too low


    Systolic and diastolic blood pressure and heart vascular events have important implications, but rarely consider at the same time
    .


    This study attempted to simultaneously analyze the associated risks of systolic blood pressure (SBP) and diastolic blood pressure (DBP) measurements and major comprehensive outcomes such as all-cause death, myocardial infarction (MI), congestive heart failure (CHF), or stroke


    .


    This study attempted to simultaneously analyze the associated risks of systolic blood pressure (SBP) and diastolic blood pressure (DBP) measurements and major comprehensive outcomes such as all-cause death, myocardial infarction (MI), congestive heart failure (CHF), or stroke


    The study analyzed data from the ALLHAT trial, which randomly divided adults into chlorthalidone, amlodipine, or lisinopril


    .


    The study analyzed data from the ALLHAT trial, which randomly divided adults into chlorthalidone, amlodipine, or lisinopril


    The results showed that during an average follow-up period of 4.


    In summary, the study confirmed that the relationship between blood pressure and stroke is linear.


    In the ALLHAT study, there is no J-shaped curve between stroke risk and systolic or diastolic blood pressure, and a linear relationship remains at the 110/55mmHg level


    In summary, in summary,

    In general, the risk pattern of systolic and diastolic blood pressure varies with clinical outcomes, and systolic and diastolic blood pressure are associated with the lowest risk
    .
    The results of this study indicate that the personalization of blood pressure goals may partly depend on the patient's most dangerous cardiovascular event, that is, which cardiovascular risk the patient faces is the highest, and it may be necessary to adopt different individualized blood pressure target values


    .


    In general, the risk pattern of systolic and diastolic blood pressure varies with clinical outcomes, and systolic and diastolic blood pressure are associated with the lowest risk


    Original source:

    Nathan K.


    Itoga , et al.
    Contributions of Systolic and Diastolic Blood Pressures to Cardiovascular Outcomes in the ALLHAT Study

    Nathan K.
    Itoga Contributions of Systolic and Diastolic Blood Pressures to Cardiovascular Outcomes in the ALLHAT Study

    J Am Coll Cardiol .
    2021 Oct , 78 (17) 1671–1678

    J Am Coll Cardiol J Am Coll Cardiol .
    2021 Oct 2021 Oct , 78 (17) 1671–1678

    https:// https:// class="tgt" data-section="2"> 

    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.